International Business News - SVNT http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the stock activity stories for Tuesday, Nov. 25, from AP Financial News: NEW YORK (AP)--An RBC Capital Markets analyst lowered his estimates and price target for Microsoft Corp. Tuesday, citing "uncertain" end-of-the-year consumer and enterprise spending and a lack of upcoming stock catalysts. http://www.ibtimes.com/articles/20081125/movers-roundup-microsoft-savient-pharma.htm Tue, 25 Nov 2008 14:26:27 EST Continued concerns over potential regulatory delays for Savient Pharmaceuticals Inc.'s gout drug candidate sent shares lower Tuesday. The stock shed 53 cents, or 12.7 percent, to reach $3.65 in afternoon trading. Shares have traded between $2.80 and $28.42 over the last 52 weeks. http://www.ibtimes.com/articles/20081125/savient-shares-fall-gout-drug-concerns-linger.htm Tue, 25 Nov 2008 13:32:35 EST Savient Pharmaceuticals Inc. said Wednesday President and Chief Executive Christopher Clement resigned. The company did not give a reason for the resignation. Clement joined the company in 2002. http://www.ibtimes.com/articles/20081119/savient-ceo-christopher-clement-resigns.htm Wed, 19 Nov 2008 07:51:43 EST Shares of Savient Pharmaceuticals plunged Monday as Wall Street urged caution over the safety profile of the drug developer's candidate for gout treatment Puricase. http://www.ibtimes.com/articles/20081027/savient-shares-fall-over-gout-drug-safety-concerns.htm Mon, 27 Oct 2008 18:17:41 EDT Shares of Savient Pharmaceuticals fell Friday after the company said it is still searching for a partner on its lead drug candidate, the gout treatment Puricase. http://www.ibtimes.com/articles/20080926/savient-shares-fall-as-it-still-seeks-partner.htm Fri, 26 Sep 2008 19:25:25 EDT Savient Pharmaceuticals Inc. said Friday it is still reviewing business development options for its lead drug candidate Puricase, and said it plans on asking regulators to approve the prospective gout treatment by the end of October. http://www.ibtimes.com/articles/20080926/savient-still-reviewing-business-options-for-drug.htm Fri, 26 Sep 2008 08:34:35 EDT Among the earnings stories for Thursday, Aug. 7, from AP Financial News: HOUSTON (AP)--Oil and natural-gas producer Swift Energy Co. said Thursday its second-quarter profit more than doubled on high commodity prices and strong operational results. http://www.ibtimes.com/articles/20080807/earnings-roundup-swift-energy-xenoport.htm Thu, 07 Aug 2008 15:17:40 EDT Shares of Savient Pharmaceuticals Inc. fell Thursday after the company reported a wider-than-expected second-quarter loss on lower revenue and higher operating expenses. http://www.ibtimes.com/articles/20080807/savient-shares-fall-on-wider-than-expected-2q-loss.htm Thu, 07 Aug 2008 11:59:57 EDT Savient Pharmaceuticals Inc. said Thursday an appeals court upheld a lower court's decision to dismiss a class action lawsuit against the drug developer, originally filed in 2002 and alleging fraud. http://www.ibtimes.com/articles/20080703/savient-claims-appeals-court-decision.htm Thu, 03 Jul 2008 16:19:54 EDT As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs who have secured lucrative research and development partnerships. http://www.ibtimes.com/articles/20080521/partnerships-drive-big-stock-gains-for-small-biotechs.htm Wed, 21 May 2008 16:58:51 EDT